19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
On Feb. 18, 2019, the New York City Commission on Human Rights released new legal enforcement guidan...
Read More >
Does your parental leave or "bonding time" policy provide more time off to one gender over the other...
Read More >
As the dust continues to settle from the General Assembly, bills that didn’t get a lot of press bef...
Read More >
On March 13, 2020, the Federal Trade Commission (“FTC”) and the Department of Justice (“DOJ”) an...
Read More >
The IRS issued final regulations on June 20, 2019 (the “Final Regulations”), which will allow empl...
Read More >
Massachusetts employers should be making their final preparations for the Massachusetts Paid Family ...
Read More >